Official Title
Academic-Community Team for Improving Vaccine Acceptability and Targeted Engagement: Public Housing
Brief Summary

This multilevel, multidisciplinary, theoretically based, culturally sensitive,community-engaged intervention sets out to mitigate uptake barriers and non-adherence tovaccination schedules as recommended by the CDC and increase influenza, meningitis,pneumonia, VZV, and COVID-19 vaccine rates among under-resourced African American andLatino public housing residents in South Los Angeles.

Detailed Description

Vaccinations are critical for preventing infectious diseases such as influenza,
meningitis, pneumonia, varicella zoster virus (VZV), and COVID-19. Despite increasing
national distribution and promotion of routine recommendations for adult vaccination,
coverage remains low, with historically lower uptake among racial and ethnic minorities.
This is compounded by higher levels of vaccine hesitancy, which may be attributed to a
myriad of issues, including worsening social determinants, medical mistrust, and lack of
access to health services. Specifically, African American and Latino public housing
residents may benefit from public health campaigns and vaccination initiatives to support
high vaccine uptake and confidence. This R01 proposal seeks to expand on a proven,
multilevel, multidisciplinary, theoretically based, culturally sensitive,
community-engaged intervention by expanding the Academic-Community Team for Improving
Vaccine Acceptability and Targeted Engagement (ACTIVATE) program. Guided by a fusion of
the Social-Ecological framework (SEM) and the Practical, Robust Implementation and
Sustainability Model (PRISM), the ACTIVATE program is inclusive of health factors on the
individual, interpersonal, community, and societal level and elements for successful
implementation. Led by leadership triads of public housing resident leaders, nurse
practitioner students, and public health students, the ACTIVATE program centers on
mitigating uptake barriers and non-adherence to vaccination schedules as recommended by
the CDC and to increase influenza, meningitis, pneumonia, VZV, and COVID-19 vaccine rates
among under-resourced AA and Latino adults in South LA.

Completed
Pneumonia
Influenza
Varicella Zoster
Meningitis
COVID-19
Vaccine Hesitancy

Behavioral: Increasing Willingness and Uptake of Influenza, Pneumonia, Meningitis, HZV, and COVID-19 Vaccination

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to
reduce Influenza, Pneumonia, Meningitis, HZV, and COVID-19 vaccine hesitancy and increase
willingness and uptake in Influenza, Pneumonia, Meningitis, HZV, and COVID-19
vaccination.

Eligibility Criteria

Aim 3:

Inclusion Criteria:

- identify as Latinx or African American

- age 18 or older

- reside in one of the six collaborating public housing area

- Speak either English or Spanish

- Report vaccine hesitancy

Exclusion Criteria:

- Not a resident at one of the collaborating public housing areas

- Does not self-identify as African American or Latinx

- Age 17 and younger

- Unable to speak either English or Spanish

- Received all recommended vaccines for Influenza, Pneumonia, Meningitis, VZV, and
COVID-19

- No reporting of vaccine hesitancy

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

Charles R. Drew University of Medicine & Science
Los Angeles 5368361, California 5332921, United States

Not Provided

Charles Drew University of Medicine and Science
NCT Number
MeSH Terms
Pneumonia
Influenza, Human
Meningitis
COVID-19
Vaccination Hesitancy